| Methods |
randomisation was generated centrally and women were randomised within centres; sealed opaque envelopes |
| Participants |
multicentre trial, 78 hospitals and family planning clinics from 8 provinces in China; 17542 pregnant women, ≤ 49 days of amenorrhoea, pregnancy confirmed by gynaecological examination, urine pregnancy test or ultrasound;
women were included if there was no history of medical disorders, no IUCD in situ and no contraindication for the study medication |
| Interventions |
mifepristone 150mg divided into 5 doses taken orally within 3 days
group 1: prostaglandin F2alpha 1mg/pv 36‐48 h after first dose of mifepristone
group 2: misoprostol 600mcg/po 36‐48 h after first dose of mifepristone |
| Outcomes |
complete, incomplete abortion, duration of vaginal bleeding, time to resume menses, side effects, women's satisfaction with the procedure |
| Notes |
1 woman had an allergic shock after misoprostol (group 2) |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Low risk |
A ‐ Adequate |
